Category Archives: News

Fast-growing Tampa digital firm snares $4 million local venture investment

Ballast Point Ventures has invested in Symphonic Distribution Inc.

The $4 million is the first outside capital invested in Symphonic, based in Tampa and one of the largest independent music companies in the industry.

Symphonic, which partners with Apple Music, Spotify, Amazon, Pandora and others, provides new and established record labels and individual musicians with digital music distribution tools that allow content creators to quickly and cost effectively distribute their music to major music consumption platforms.

Full Article: Tampa Bay Business Journal

Ballast Point Ventures Announces Successful Exit From TicketBiscuit

Tampa, FL – October 30, 2017

Ballast Point Ventures III, LP (“BPV”) is pleased to announce that it has successfully exited its growth equity investment in TicketBiscuit, a Birmingham-based online ticketing and event platform, through an acquisition by eTix. BPV invested in TicketBiscuit to help the Company grow its salesforce, bolster marketing efforts, and develop additional technology products.

Founded in 2001 by Chief Executive Officer, Jeff Gale, TicketBiscuit has a rich history of pioneering innovations in online ticketing, including mobile ticketing, seatPOWER® high-demand reserved seating, and Share and Tear® scanner-free admission control. TicketBiscuit provides a suite of ticketing software and services to music venues, comedy clubs, festivals, event centers and many other attractive niche vertical markets across the country, and experienced strong organic growth in these markets during BPV’s investment period.

Robert Faber, a Partner with BPV, served on TicketBiscuit’s board of directors prior to the acquisition. He remarked, “We are pleased to have partnered with the outstanding management team at TicketBiscuit and appreciate their excellent work in creating substantial value for all the shareholders. TicketBiscuit fits the profile of the type of well-managed, rapidly growing firms in the Southeast with which Ballast Point Ventures seeks to partner.  In addition, we were pleased to be a part of helping to build a successful company in the burgeoning Birmingham technology community where our firm has deep ties and interest.”

“Our team has worked relentlessly to build and support cutting edge technology and provide the best ticketing experience on the planet, and we are pleased to see that hard work pay off in a compelling combination with eTix” said Jeff Gale, Founder and CEO of TicketBiscuit. He continued, “Ballast Point Ventures was a great partner for us at our stage of development, and we greatly enjoyed working with Robert and the team at BPV.”

About TicketBiscuit
Headquartered in Birmingham, AL, TicketBiscuit provides proprietary software that powers the online ticket sales of over 2,000 clients and partners across North America and around the world. TicketBiscuit’s complete suite of services and solutions empowers clients to sell tickets online through mobile optimized websites, telephone call center, and the TicketBiscuit web-based box office interface.  For more information on TicketBiscuit, please visit http://www.ticketbiscuit.com

About BPV
Ballast Point Ventures, headquartered in Tampa, Florida, is a later stage venture capital and growth equity firm founded in 2002 to provide expansion capital for rapidly growing, privately owned companies, with a particular emphasis on companies located in the Southeast and Texas.  The BPV partners have more than 80 years of combined experience investing in and building high-growth companies in several industries, including health care, software, technology-enabled business services, communications, and consumer.  BPV has $360 million under management and seeks to make initial equity investments ranging in size from $4 million to $10 million. For more information on Ballast Point Ventures, please visit http://ballastpointventures.com/

MolecularMD Announces Partnership with Indica Labs

SOURCE: StockGuru.com

PORTLAND, Ore. and CAMBRIDGE, Mass., Sept. 28, 2017 (GLOBE NEWSWIRE) — MolecularMD, a provider of molecular and tissue-based clinical trial assays and diagnostics for oncology based drug development programs, has announced a partnership agreement with Indica Labs, a leader in digital pathology imaging tools and services.

The collaboration between the companies leverages MolecularMD’s diagnostic clinical testing solutions with Indica Labs’ digital biomarker analysis services to enable an efficient transition of pre-clinical research to the diagnostic setting and deployment of advanced image analysis workflows. Mindful that many of its clients are using Indica Labs’ products and services, MolecularMD envisions the partnership will facilitate seamless transition of image analysis methods to the clinical trial setting for accelerated drug development programs.

“Indica Labs’ HALOTM image analysis software and the HALO LinkTM image management system provides advanced image analysis capabilities in a global collaborative environment,” said Doug Bowman, Vice President of Pharma Services at Indica Labs.  “This agreement will allow our clients to take advantage of MolecularMD’s capabilities, and MolecularMD’s clients to develop quantitative assays to better understand biomarker expression levels and spatial relationships relative to the tissue microenvironment.”

“The agreement will provide our clients with integrated genomic and phenotypic biomarker analyses that are crucial for accurate and effective patient stratification,” said Dan Snyder, President and Chief Executive Officer at MolecularMD.

“Indica Labs fills our clients’ needs for digital biomarker analysis and enhances our proposition to immuno-oncology development programs. These capabilities will provide unique advantages and accelerate pipeline decisions. The use of advanced algorithms for IHC data interpretation holds the possibility of improved patient outcomes,” said Snyder.

Indica Labs will attend the Pathology Visions 2017 Conference; which brings together the luminaries and key opinion leaders in digital pathology. More information about the partnership can be found at the Indica Labs Booth #7. Pathology Visions 2017 will be held from October 1-3, 2017 in San Diego at the Manchester Grand Hyatt. For more information about Pathology Visions 2017, click here.

About MolecularMD
MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. MolecularMD integrates gold standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Dr. Brian Druker, director of the Knight Cancer Institute at Oregon Health & Science University, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation.  Learn more at www.molecularmd.com

Contact Information:
Fritz Eibel, SVP and Chief Marketing Officer
feibel@molecularmd.com

About Indica Labs
Indica Labs is the first company to offer tissue specific and application specific image analysis algorithms in a truly integrated digital pathology environment. Pharmaceutical, healthcare, and research organizations worldwide utilize Indica tools for high-throughput, whole-slide image quantification in areas such as neuroscience, metabolism, oncology, toxicological pathology, and more. Learn more at www.indicalab.com

Contact information:
Douglas Bowman, VP of Pharma Services
dbowman@indicalab.com

TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer

SOURCE: TissueTech, Inc.

MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary liaison for medical affairs, has more than 25 years of healthcare industry-based experience, most recently at Smith & Nephew plc, where he was CMO and Senior Vice President of Research and Development for the wound care division.

Dr. Slade’s previous research background includes prestigious work with Dr. Jonas Salk, who developed one of the first successful polio vaccines. Dr. Salk recruited Dr. Slade from academia to develop an HIV therapeutic vaccine joint venture, where Dr. Slade held the position of Director of AIDS and Immunology at Rhône-Poulenc Rorer.

Dr. Slade later became CMO of 3M Pharmaceuticals for 12 years. Following that appointment, he joined DFB Pharmaceuticals, serving as CMO for Healthpoint Biotherapeutics. After Healthpoint was acquired by Smith & Nephew in 2012, Slade’s role expanded to include their wound care division.

“It is with great enthusiasm that I join the TissueTech executive team. As the first company to commercialize amniotic membrane based technologies for clinical use, it is a pioneer in the field of regenerative medicine,” said Dr. Slade. “The company has an innovative vision for the future development of this platform technology, and I know that my experience in clinical development can be an asset to support the company in achieving those objectives.”

Dr. Slade received his undergraduate degree in biology from Hamilton College and his M.D. from State University of New York Upstate Medical University in Syracuse, New York.

“In addition to being a dual board-certified subspecialist in pediatrics and clinical immunology, Dr. Slade has played pivotal roles in key medical research for a number of reputable companies,” said Amy Tseng, Chief Executive Officer of TissueTech. “As our company continues to grow – we recently achieved the milestone of 300,000 human implants performed by clinicians –an individual with the credentials and knowledge that Dr. Slade provides necessary support for our mission to continue to provide clinicians with advanced regenerative medicine therapies that improve patients’ lives.”

About TissueTech, Inc.

TissueTech, Inc., the parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., pioneered the development and clinical application of regenerative, amniotic tissue-based products. Amniox Medical markets products for use in the musculoskeletal and wound care markets; Bio-Tissue markets products for the ophthalmology and optometry markets. The National Institutes of Health (NIH) has supported TissueTech’s research with more than 30 continuous years of research grants. Since the company’s inception, clinicians have performed more than 300,000 human implants of the company’s products and published more than 300 peer-reviewed studies supporting its technology platform. The company’s first product, AmnioGraft®, is the only tissue graft designated by the FDA as homologous for promoting ophthalmic wound healing while suppressing scarring and inflammation.

Media Contact: Chris Gale, cgale@greentarget.com

BPV Invests in Pensacola-based Intelligent Retinal Imaging Systems

Intelligent Retinal Imaging Systems Raises Series B Growth Funding

SOURCE: Intelligent Retinal Imaging Systems, LLC

PENSACOLA, Fla.—June 20, 2017Intelligent Retinal Imaging Systems, Inc. (IRIS), the industry leader in early detection systems for diabetic eye disease, today announced the company successfully closed a round of Series B financing. The round was led by Ballast Point Ventures, a later-stage venture capital and growth equity firm that invests in rapidly growing, privately owned companies in the health care and technology industries. The round also includes investments from two healthcare system funds, Providence Ventures and current IRIS customer, CoxHealth. Funds raised will be used to support the company’s expansion and growth strategy as well as to support IRIS’s goal of developing the next generation of products that detect eye disease and improve the monitoring and care of patients in diabetic populations.

“IRIS was founded with the idea that through innovative and forward-thinking preventative care systems, we could save the sight of millions of patients,” said IRIS Founder and Chief Medical Officer, Dr. Sunil Gupta. “Everyone deserves a lifetime of sight. I am pleased that Ballast Point Ventures, Providence Ventures and CoxHealth have joined IRIS to improve the lives of patients with diabetes and see the value in our goal to develop the next generation of solutions.”

“With the capital from this financing, IRIS will be able to build on its leading position in the market while continuing to innovate and serve its forward-thinking health system clients,” said Matt Rice, Partner at Ballast Point Ventures. “We are excited to partner with Dr. Sunil Gupta, Jason Crawford, and the entire IRIS team to execute on the company’s mission of ending preventable blindness.”

“IRIS is emblematic of Providence Ventures’ investment strategy. Our fund’s interest was driven by deep insights collected from our Providence St. Joseph Health operating colleagues, and their enthusiasm regarding IRIS’s diverse and important value proposition. Providence St. Joseph Health’s clinical leaders are excited about the potential of the IRIS solution to dramatically enhance our ability to care for diabetic patients,” added Jeff Stolte, Partner at Providence Ventures.

“CoxHealth and IRIS have developed a partnership that has produced meaningful outcomes for our patients,” said Jake McWay, Senior Vice President and CFO of CoxHealth. “In recognition of the results we achieved over the last year, we were jointly awarded a 2017 Microsoft Health Innovation Award. We are excited to see the impact of this expansion and investment, and believe great things are ahead for this collaboration.”

The IRIS retinal telemedicine platform was developed to help end preventable, permanent blindness caused by diabetic retinopathy through early diagnosis. The IRIS platform is in place at 94 health systems across 28 states. IRIS seamlessly sits within a primary care physician’s existing workflow, dramatically increasing a health system’s ability to achieve superior annual diabetic retinopathy compliance rates. IRIS enables health systems to increase access, improve care coordination, lower costs and achieve 5-Star outcomes. In four years, IRIS clients have examined 183,498 patients with diabetes and found sight-threatening disease in nearly 31,624. One-third of the patients examined with the IRIS technology have been diagnosed with some form of retinal pathology.

“Great strides have been made to unseat diabetic retinopathy as the leading cause of blindness worldwide. The only barrier to success is early detection. IRIS closes the care gap for those patients that do not receive annual diabetic retinal exams. This investment will allow IRIS’s committed team and partners to execute to our vision of preventing blindness both here in the U.S. and worldwide,” added Dr. Gupta.

“Ballast Point Ventures, Providence Ventures and CoxHealth bring a deep understanding of the importance of population health management,” said IRIS CEO, Jason Crawford. “This investment will help us continue to improve the infrastructure, technology and services we deliver to our customers. It will lead to innovation that will place IRIS in a strong position to fuel the future of our product and improve the lives of every patient with diabetes that we touch.”

Matt Rice from Ballast Point Ventures and Jeff Stolte from Providence Ventures will join the IRIS Board of Directors, and Dr. C. Mark Costley, M.D. of CoxHealth will serve as Chair of IRIS’s newly established Clinical Advisory Board.

IRIS was advised by Ziegler, a healthcare-focused investment bank headquartered in Chicago, Ill.

About Ballast Point Ventures

Ballast Point Ventures is a later-stage venture capital fund established to provide expansion capital for rapidly growing, privately owned companies in diverse industries, with a particular emphasis on companies located in the Southeast and Texas. The BPV partners have more than 70 years of combined experience investing in and building high-growth companies in a number of industries, including healthcare, business services, communications, technology, financial services and consumer. BPV has $360 million under management and seeks to make equity investments ranging in size from $4 million to $12 million. www.ballastpointventures.com

About Providence Ventures and Providence St. Joseph Health

Providence Ventures was founded in 2014 to manage a $150 million venture capital fund on behalf of Providence St. Joseph Health. Providence Ventures aims to drive innovation across the health care system to improve quality and convenience, lower cost and create better health outcomes. Providence St. Joseph Health is a new organization created by Providence Health & Services and St. Joseph Health with the goal of improving the health of the communities it serves, especially those who are poor and vulnerable. Together, its 111,000 caregivers (all employees) serve in 50 hospitals, 829 clinics and a comprehensive range of services across Alaska, California, Montana, New Mexico, Oregon, Texas and Washington.

About CoxHealth
CoxHealth is the only locally owned, not-for-profit health system based in Springfield, Mo., and is nationally accredited by DNV GL – Healthcare. Established in 1906, the organization serves a 25-county service area in southwest Missouri and northwest Arkansas, offering a comprehensive array of primary and specialty care through five hospitals and more than 80 clinics. CoxHealth also serves the unmet needs of its friends and neighbors by providing more than $148 million annually in community benefit. The health system includes Cox Medical Center South, Cox Medical Center Branson, Cox North Hospital, Meyer Orthopedic and Rehabilitation Hospital, Cox Monett Hospital, Oxford HealthCare (the nation’s second largest hospital-based home health agency), Home Parenteral Services (home infusion therapy), CoxHealth Foundation, Cox College, Cox HealthPlans and more.

About Intelligent Retinal Imaging Systems

Intelligent Retinal Imaging Systems (IRIS) is the industry leader in early detection systems for diabetic eye disease. The company’s IRIS solution is an end-to-end FDA-cleared, telemedicine system that has improved quality, expanded access and reduced costs for diabetic retinopathy exams across the U.S. IRIS was founded in 2011 by nationally recognized retina surgeon Dr. Sunil Gupta, with a vision to end preventable blindness through the development and deployment of retinal diagnostic services in the primary care setting. The IRIS team of physicians, technicians and best practice client success experts partner with forward-thinking providers and payers to enhance patient outcomes by closing care gaps in healthcare systems. IRIS is the recipient of the 2017 Microsoft Innovation Award and the 2016 Frost & Sullivan New Product Innovation Award in Diabetic Retinopathy. For additional information, visit www.retinalscreenings.com

Iconixx Named among ‘50 Fastest Growing Companies of the Year 2017’ by The Silicon Review Magazine

AUSTIN, Texas–(BUSINESS WIRE)–Iconixx today announced that The Silicon Review Magazine has named it among the ‘50 Fastest Growing Companies of the Year 2017.’

“We are honored to be recognized by The Silicon Review Magazine as the one of the 50 Fastest Growing Companies of the Year 2017”

Tweet this

“The Silicon Review 50 Fastest Growing Companies of the Year 2017 program identifies companies which are revolutionizing the decision making and business growth process, and winning a spot on this list indicates the company has not only distinguished itself from peers by proving itself as one of the fastest growing companies but also helping other companies to gain momentum in the marketplace,” said Sreshtha Banerjee, Editor-in-Chief of The Silicon Review Magazine. The publication has selected Iconixx based on its financial growth, ability to retain customers, frequent innovation, and contribution to the IT sector at large.

“We are honored to be recognized by The Silicon Review Magazine as the one of the 50 Fastest Growing Companies of the Year 2017,” said Derrik Deyhimi, Founder and CEO at Iconixx. “We are very proud of our product, sales and customer service accomplishments, and expect to see that accelerated in the next year.”

Iconixx has increased its sales force significantly to continue its momentum of growth. The team is focused on making their customers’ lives better through product innovation and its unrivaled customer support.

About Iconixx

Within every sales professional is a primal, quota-crushing beast. If you’re responsible for managing compensation, you are the beastmaster. The beastmaster has no time for tedious compensation routines using inferior tools like spreadsheets. The beastmaster, meanwhile, cannot abide the irritation of manual commission reconciliations. No. The beast cares only for the hunt. Iconixx is a sales compensation solution that automates commission plans and eliminates sales downtime caused by trivial administration. So get Iconixx – and unleash the beast. Iconixx is headquartered in Austin, Texas, and is online at www.iconixx.com.

HotSchedules Announces New CEO, Changes to Leadership Team and Record Usage Numbers

News Provided on May 16, 2017 by HotSchedules

AUSTIN, TX – MAY 16, 2017 – HotSchedules®, a leading provider of technology solutions for the restaurant and hospitality industries, announced Mike Arenth as Chief Executive Officer. Arenth started with the company in late 2016 and implemented key leadership changes to better support innovation and growth. Prior to joining HotSchedules, Arenth was a Senior Advisor to Silver Lake, an Executive Vice President at SAP and before that spent 10 years at Ariba as General Manager and Senior Vice President.

“Restaurants remain economic powerhouses but technology is rapidly changing the industry and I’m confident that Mike is the right person to lead HotSchedules forward,” said Kevin Costello, Chairman of HotSchedules. “He is a seasoned executive with proven ability to create strategic clarity, focus an organization and drive innovation and growth particularly in industries facing transformation.”

“HotSchedules is built on a solid foundation— great products, strong financials, very engaged users, world-class customers and a talented team dedicated to meeting the ever-changing needs of this evolving industry,” said Arenth. “I’m honored and excited to lead HotSchedules to create the next generation of intelligent back-of-house solutions that will help our customers drive into the future—thoughtfully, efficiently, successfully and profitably.”

The company also announced record usage numbers for its popular platform designed to streamline back-of-house operations including training, scheduling, time & attendance, shift communications, task management, inventory, financials and analytics. HotSchedules serves over 2 million users in over 130,000 locations across 26 countries.

In 2016 alone, HotSchedules customers:
  • Scheduled 1.6 BILLION hours
  • Exchanged 224 MILLION messages
  • Traded 12.5 MILLION shifts
  • Completed over 5 MILLION online training courses
  • Completed over 1 MILLION online training certifications
  • Generated over $65 BILLION in restaurant sales
  • Purchased $24 BILLION in inventory through the platform

To further strategic momentum, the company has expanded its leadership team to include a dynamic group of executives to compliment the deep restaurant industry experience of Co-Founder David Cantu and the existing HotSchedules team.

The new leadership team includes:
  • Ted Kondis, Chief Revenue Officer who brings experience in general management and sales from Ariba, Arthur Anderson and SAP.
  • Neville Letzerich, Chief Marketing Officer who previously served as CMO at Forcepoint, LLC. Prior to that Letzerich held executive, product, marketing and consulting roles at EMC, Bazaarvoice and Accenture.
  • Sean Fitzpatrick, Chief Operations Officer has been with the company for 3 years and is promoted to COO. Fitzpatrick previously served as Global Vice President of Strategy and Innovation at Oracle and has held senior leadership at BearingPoint, BroadVision and Lucent Technologies.
  • Brian Gaffney, Senior Vice President of Engineering: After more than three years of engineering leadership within HotSchedules, Gaffney has been promoted to SVP Engineering. Prior to that, he spent fifteen years at software start-ups including, AmberPoint, App Dynamics, Symplified, and Emotive Communications.
About HotSchedules

HotSchedules provides mobile, cloud-based technology for the restaurant, retail and hospitality industries. The company is committed to serving those who serve others through a comprehensive suite of solutions that make working for and in restaurants – and beyond – more rewarding and efficient. The product suite solves the challenges associated with training, scheduling and managing labor, back-of-house operations and communications. HotSchedules is proud to serve more than 2 million users in over 130,000 locations across 26 countries. For more information visit: https://www.hotschedules.com.

Media Contact: Ryan Bearden, ryan.bearden@hotschedules.com

Iconixx Software Closes $4.2 Million Equity Financing

Posted May 2nd, 2017 by Business Wire

AUSTIN, Texas–(BUSINESS WIRE)–Iconixx software announces today it has closed $4.2M in new capital. This round of funding was led by existing investors Ballast Point Ventures, Harbert Growth Partners, S3 Ventures, and the Iconixx management team, resulting in $24 million in capital raised to date.

Iconixx, a global leader in enterprise class incentive compensation software, will use the funding to accelerate growth initiatives. The company has plans for product advancements and continued increase in market share by expanding its robust sales team.

“Our solid sales pipeline, proven customer success accomplishments, and product enhancements have propelled our rapid growth and award-winning customer support team. The hard work of our skilled team has driven our successes, and we expect to see these accelerated,” said Derrik Deyhimi, Chairman and CEO of Iconixx. “We are excited about our future growth and making the lives of each of our customers better.”

“We are proud of the accomplishments Iconixx software has achieved in product enrichments, customer acquisition and customer success. Our overwhelming confidence in the Iconixx compensation management solution leaves us excited for the continued partnership with the team,” says Matt Rice, Partner at Ballast Point Ventures.

About Iconixx

Iconixx software listens intently to every customer’s challenge – treating every interaction as an opportunity to understand the unique compensation needs of each customer. We carefully diagnose the problem and prescribe an automated path by configuring our software to remedy critical compensation issues. Your cure is our success! http://www.iconixx.com/

About S3 Ventures

S3 Ventures is an early, expansion and growth stage venture firm with $200 million under management. The firm is focused on information technology solutions that solve large business problems and in medical devices that improve the human condition. S3 invests across all stages of a company’s growth and partners with the team to help focus methodically on what it takes to build a successful company. www.s3vc.com

About Harbert Growth Partners Funds (the “HGP Funds”)

The Harbert Growth Partners Funds are emerging growth stage investors focused on rapidly growing technology and healthcare companies headquartered in the Mid-Atlantic and Southeastern United States. The HGP Funds are affiliates of Harbert Management Corporation (“HMC”), an alternative asset management company which manages approximately $4.4 billion in Regulatory Assets Under Management as of June 30, 2016, from offices in 11 locations across the United States and Europe. http://www.harbert.net/

About Ballast Point Ventures

Ballast Point Ventures is a later stage venture capital fund established to provide expansion capital for rapidly growing, privately owned companies in diverse industries, with a particular emphasis on companies located in the Southeast and Texas. The BPV partners have more than 70 years of combined experience investing in and building high-growth companies in a number of industries, including healthcare, business services, communications, technology, financial services and consumer. BPV has $360 million under management and seeks to make equity investments ranging in size from $4 million to $12 million. www.ballastpointventures.com.

BigTeams, StateChamps partner to provide online ticketing to high schools

Posted March 17th, 2017 by StateChamps

BigTeams, the leading high school sports software platform in the US, has announced that it has partnered with Birmingham, Alabama-based StateChamps.com to provide online ticketing services to BigTeams client high schools.

“Increasingly, our clients and their fans have been asking for an online ticketing solution for high schools,” said Jeff Gilbert, BigTeams Founding Partner and Chief Product Officer.  “In looking for a partner, we evaluated multiple ticketing companies’ ticketing solutions to high schools. In the end, StateChamps’ team and technology made it obvious to us that they are the winning solution” said BigTeams CEO, Joe Romano.

StateChamps’ patent-pending Share and TearTM Technology delivers electronic tickets to an app on the ticket purchaser’s smartphone. The ticket buyer then presents their phone at the gate, and the digital ticket is “torn” on screen by gate staff.  “We designed the digital tearing process to be almost identical to the paper ticket redemption process;” StateChamps Chief Marketing Officer Eric Housh explained, “it requires neither ticket scanners nor internet, and gate staff can be trained in seconds.”

In addition to Share and TearTM, StateChamps’ team of over 60 ticketing professionals power an “Omni-Service” approach. After the school sends the schedule and ticket price information, StateChamps does the work to set everything up.

“The school gets secure, powerful, and hassle-free online ticketing at no cost, with no work required,” Housh said.

The StateChamps online ticketing solution will be included at no additional cost for new and existing BigTeams and ScheduleStar client schools, and will integrate seamlessly with BigTeams and ScheduleStar. StateChamps will also provide free printed tickets to BigTeams clients.

About StateChamps

StateChamps is the exclusive online ticketing solution for hundreds of high schools nationwide, including seven state high school athletics associations. StateChamps was also recognized as a preferred vendor and online ticket supplier of the National Interscholastic Association of Athletic Administrators. For more information, please visit www.statechamps.com.

About BigTeams

BigTeams is the leading provider of technology designed to streamline communication for high school athletic communities.  BigTeams offers official websites for high school sports programs, time saving tools such as Schedule Star™, and other products designed to eliminate administrative burdens on AD’s and coaches, while connecting student athletes and fans through a single platform.

PowerChord, Inc. Hires New President to Amplify Global to Local Solutions

Posted March 15th, 2017 by PowerChord

PowerChord, a leading SaaS company that transforms how brands drive local sales, welcomed newly appointed company President, Steven Roth, to their growing executive team.

Roth joins the SaaS organization with almost 20 years of experience working with top-tier retailers, manufacturers and agencies from around the world. His addition brings a deep expertise in product innovation to PowerChord and will provide a strong foundation for the development of global enterprise level, eCommerce and retail advertising solutions at the hyper local level.

Hailing from Google, he has spent the past four years as a Group Product Manager after developing technology that is now part of Google Shopping during his tenure at Channel Intelligence – the Florida-based, global technology company acquired by Google in 2013. While at Channel Intelligence, Roth’s revenue breaking, international solutions were utilized in over 30 countries and operated across all corresponding languages and currencies. Previously, Roth held roles at Altiris / Wise Solutions, Profitstar and Metavante.

As PowerChord’s new President, Roth’s focus will center around expanding the comprehensive suite of products in the PowerChord Platform to increase long-term value and the scalable efficiencies that allow global businesses to control their brand, engage customers, and drive local sales through their dealer networks.

Roth will also propel the company towards emerging technologies and market-leading, digital solutions to meet the growing needs of the multi-location marketplace, while further optimizing the connection between online consumers and the global to local retail community.

“We have to think big” said Roth, “because that forces you to scale. I’m looking forward to that process and the exploration of how the needs of the market will influence us to move forward – the sky’s the limit when it comes to innovation. It’s a unique time in the company’s history and I appreciate the opportunity to be a part of it.”

“We’re honored to welcome Steven to the PowerChord team” said PowerChord CEO, Lanny Tucker. “We’re confident that his vision and operational excellence will bring exciting progress to our position as a SaaS leader and continue enhancing the company’s global value proposition for clients across a wide range of industry landscapes.”

© 2017 Ballast Point Ventures. All rights reserved.